Pharmacogenomic genotypes define genetic ancestry in patients and enable population-specific genomic implementation.

MLA

Hernandez, Wenndy, et al. “Pharmacogenomic Genotypes Define Genetic Ancestry in Patients and Enable Population-Specific Genomic Implementation.” The Pharmacogenomics Journal, vol. 20, no. 1, Feb. 2020, pp. 126–35. EBSCOhost, https://doi.org/10.1038/s41397-019-0095-z.

APA

Hernandez, W., Danahey, K., Pei, X., Yeo, K.-T. J., Leung, E., Volchenboum, S. L., Ratain, M. J., Meltzer, D. O., Stranger, B. E., Perera, M. A., & O’Donnell, P. H. (2020). Pharmacogenomic genotypes define genetic ancestry in patients and enable population-specific genomic implementation. The Pharmacogenomics Journal, 20(1), 126–135. https://doi.org/10.1038/s41397-019-0095-z

Chicago

Hernandez, Wenndy, Keith Danahey, Xun Pei, Kiang-Teck J Yeo, Edward Leung, Samuel L Volchenboum, Mark J Ratain, et al. 2020. “Pharmacogenomic Genotypes Define Genetic Ancestry in Patients and Enable Population-Specific Genomic Implementation.” The Pharmacogenomics Journal 20 (1): 126–35. doi:10.1038/s41397-019-0095-z.